One thing I couldn't figure out was what needs to be done to change the phase 3 trial to twice weekly dosage? It says that once weekly has no meaningful change over placebo so they need to adjust the dosage plan for the phase 3. Will that require any new application to the FDA or just an adjustment within the trial? Might have read it wrong so feel free to point me out on it.
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS, page-21
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $187.1K | 755.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 47906 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 13363 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |